Q2
COCP — Q2 2026 Financial Report Analysis
Cocrystal's Q2 2026 net loss widened 54% to $3.2 million as its norovirus challenge trial ramped up, leaving just $2.2 million of cash at June 30 before a $5.0 million insider-linked share sale that management says still won't fund the next 12 months.